Literature DB >> 27063352

Computed Biological Relations among Five Select Treatment-Related Organ/Tissue Toxicities.

Theodore Sakellaropoulos1, Timothy J Herod1, Leonidas G Alexopoulos2, Jane P F Bai1.   

Abstract

Drug toxicity presents a major challenge in drug development and patient care. We set to build upon previous works regarding select drug-induced toxicities to find common patterns in the mode of action of the drugs associated with these toxicities. In particular, we focused on five disparate organ toxicities, peripheral neuropathy (PN), rhabdomyolysis (RM), Stevens-Johnson syndrome/toxic epidermal necrosis (SJS/TEN), lung injury (LI), and heart contraction-related cardiotoxicity (CT), and identified biological commonalities between and among the toxicities in terms of pharmacological targets and nearest neighbors (indirect effects) using the hyper-geometric test and a distance metric of Spearman correlation. There were 20 significant protein targets associated with two toxicities and 0 protein targets associated with three or more toxicities. Per Spearman distance, PN was closest to SJS/TEN compared to other pairs, whereas the pairs involving RM were more different than others excluding RM. The significant targets associated with RM outnumbered those associated with every one of the other four toxicities. Enrichment analysis of drug targets that are expressed in corresponding organ/tissues determined proteins that should be avoided in drug discovery. The identified biological patterns emerging from the mode of action of these drugs are statistically associated with these serious toxicities and could potentially be used as predictors for new drug candidates. The predictive power and usefulness of these biological patterns will increase with the database of these five toxicities. Furthermore, extension of our approach to all severe adverse reactions will produce useful biological commonalities for reference in drug discovery and development.

Entities:  

Mesh:

Year:  2016        PMID: 27063352     DOI: 10.1021/acs.chemrestox.6b00060

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  4 in total

Review 1.  Biomarkers: Delivering on the expectation of molecularly driven, quantitative health.

Authors:  Jennifer L Wilson; Russ B Altman
Journal:  Exp Biol Med (Maywood)       Date:  2017-12-03

2.  PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development.

Authors:  Jennifer L Wilson; Rebecca Racz; Tianyun Liu; Oluseyi Adeniyi; Jielin Sun; Anuradha Ramamoorthy; Michael Pacanowski; Russ Altman
Journal:  PLoS Comput Biol       Date:  2018-12-07       Impact factor: 4.475

3.  PathFXweb: a web application for identifying drug safety and efficacy phenotypes.

Authors:  Jennifer L Wilson; Mike Wong; Ajinkya Chalke; Nicholas Stepanov; Dragutin Petkovic; Russ B Altman
Journal:  Bioinformatics       Date:  2019-11-01       Impact factor: 6.937

4.  Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges.

Authors:  Hugo Geerts; John Wikswo; Piet H van der Graaf; Jane P F Bai; Chris Gaiteri; David Bennett; Susanne E Swalley; Edgar Schuck; Rima Kaddurah-Daouk; Katya Tsaioun; Mary Pelleymounter
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-11-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.